Viewing Study NCT05002868


Ignite Creation Date: 2025-12-24 @ 5:51 PM
Ignite Modification Date: 2025-12-31 @ 2:18 AM
Study NCT ID: NCT05002868
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2021-08-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors
Sponsor: Rhizen Pharmaceuticals SA
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: RP12146-2101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators